Showing results (641-650 of 730) with videos related to

Sort By:
Pageof 73
The Oncologist|September 20, 2020
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729)Melisa L Wong, Junheng Gao, Gita Thanarajasingam, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 1, 2025
Reduced Muscle Force in Dystrophic DMDΔ52 Pigs Is Incompletely Restored by Systemic Transcript Reframing (DMDΔ51-52)Michaela Blasi, Hristiyan Hristov, Jan B Stöckl, et al.
Science (New York, N.Y.)|August 17, 2023
In silico protein interaction screening uncovers DONSON's role in replication initiationYang Lim, Lukas Tamayo-Orrego, Ernst Schmid, et al.
Journal of Neuromuscular Diseases|November 25, 2017
Early-Onset Myopathies: Clinical Findings, Prevalence of Subgroups and Diagnostic Approach in a Single Neuromuscular Referral Center in GermanyK Vill, A Blaschek, D Gläser, et al.
Diagnostics (Basel, Switzerland)|December 16, 2020
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume DefinitionJosefine Graef, Carolin Senger, Christoph Wetz, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
USP37 prevents premature disassembly of stressed replisomes by TRAIPOlga V Kochenova, Giuseppina D'Alessandro, Domenic Pilger, et al.
Nature Communications|June 18, 2025
USP37 prevents premature disassembly of stressed replisomes by TRAIPOlga V Kochenova, Giuseppina D'Alessandro, Domenic Pilger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2023
Systemic deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model lacking DMD exon 52Michael Stirm, Bachuki Shashikadze, Andreas Blutke, et al.
Plos One|July 5, 2013
An integrated diagnosis strategy for congenital myopathiesJohann Böhm, Nasim Vasli, Edoardo Malfatti, et al.
Der Nervenarzt|May 13, 2020
[Recommendations for gene therapy of spinal muscular atrophy with onasemnogene abeparvovec-AVXS-101 : Consensus paper of the German representatives of the Society for Pediatric Neurology (GNP) and the German treatment centers with collaboration of the medical scientific advisory board of the German Society for Muscular Diseases (DGM)]Andreas Ziegler, Ekkehard Wilichowski, Ulrike Schara, et al.
Pageof 73